AFP and hepatocellular carcinoma: Similarly, Franck et al. observed a trend towards a better overall survival in HCC patients with low miR-122 expression levels, while statistically significant results were obtained considering the prognostic value of miR-122 in specific HCC subgroups (patients with advanced cirrhosis, advanced tumor stage and normal AFP) [77].